The QualityStocks Daily Tuesday, December 3rd, 2019

Today's Top 3 Investment Newsletters

Trades Of The Day (BOLD) +105.98%

StockMarketWatch (QHC) +65.00%

BUYINS.NET (DRIO) +49.10%

The QualityStocks Daily Stock List

Armanino Foods of Distinction, Inc. (AMNF)

Zacks, Dividend Diplomats, Super Stock Screener, Capital Cube, OTC Markets, TalkMarkets, Glassdoor, StockInvest.us, Infront Analytics, MarketBeat, Morningstar, TMXmoney, Simply Wall St, MarketWatch, Market Screener, QSR Magazine, Wallet Investor, InvestorsHub, GuruFocus, Dividend.com, Dividend Investor, TradingView, and Seeking Alpha reported previously on Armanino Foods of Distinction, Inc. (AMNF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Armanino Foods of Distinction, Inc. produces and markets frozen and refrigerated food products in the USA. It offers its products under the Armanino brand. The Company markets its products via a network of food brokers. It also sells to retail and foodservice distributors, club-type stores, as well as industrial accounts. Armanino Foods of Distinction lists on the OTC Markets. Established in 1978, the Company has its corporate headquarters in Hayward, California.

Armanino’s frozen products consist of pesto sauces, stuffed pastas, and pasta sheets. They also include Italian pastas and cooked meat products.

In addition, the Company offers cooked beef and turkey meatballs, and cheese shakers; and cooked and uncooked frozen stuffed pastas. This includes meat, butternut squash, cheese ravioli and jumbo cheese, and jumbo mushroom ravioli. Armanino also offers jumbo cheese/spinach green dough ravioli; cheese ravioli; meat filled, tri-color cheese, and cheese tortellini; and tri-color cheese and cheese capelletti, manicotti, and stuffed shells.

In the Foodservice sector, Armanino Foods of Distinction is the industry’s top source for premium frozen pesto. The Company is famous for its Basil Pesto. Armanino also offers other flavors including Cilantro, Dried Tomato & Garlic, Roasted Red Bell Pepper, Southwest Chipotle, Artichoke, Roasted Garlic, Creamy Garlic, Harissa, Romesco, Chimichurri, and Light Basil Pesto.

This past October, Armanino Foods of Distinction reported a decrease in its Net Sales and Net Income for Q3 ending September 30, 2019. Year to date Net Sales and Net Income for the nine month period ending September 30th remained higher than the same period the year prior.

Mr. Edmond J. Pera, President and Chief Executive Officer of Armanino Foods of Distinction, stated, “While this is our 65th quarter in a row of profitability, a significant decrease in purchases by our distributor in Asia, as well as higher expenditures for sales and promotional activities, drove year over year net sales and profits down for this quarter. Looking at our results from a gross vs. net sales perspective, third quarter US domestic gross sales were very robust growing by $1.3 million, or by 11 percent over last year. However, third quarter gross sales in our Asian markets declined by approximately $800,000 over the prior year.”

Armanino Foods of Distinction, Inc. (AMNF), closed Tuesday's trading session at $3.54, up 2.0173%, on 4,820 volume with 12 trades. The average volume for the last 3 months is 16,035 and the stock's 52-week low/high is $2.79999995/$3.79250001.

chart

Canacol Energy Ltd. (CNNEF)

Zacks, Investor Observer, Wallet Investor, Stockhouse, Stock Muse, StreetWise Reports, Morningstar, TradingView, GlobeNewswire, InvestorsHub, TMXmoney, Investing.com, Dividend Investor, and Market Screener reported earlier on Canacol Energy Ltd. (CNNEF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Canacol Energy Ltd. chiefly explores for, develops, and produces petroleum and natural gas in Colombia. The Company is a foremost natural gas exploration and production business in Colombia. Canacol Energy lists on the OTC Markets Group’s OTCQX. The Company is based in Calgary, Alberta.

Last month, Canacol Energy reported its financial and operating results for the three and nine months ended September 30, 2019. Realized contractual natural gas sales rose 27 percent and 17 percent to 146.4 MMscfpd and 129.7 MMscfpd for the three and nine months ended September 30, 2019, versus 115.3 MMscfpd and 111.2 MMscfpd for the same periods in 2018, respectively.

Average natural gas production volumes rose 28 percent and 18 percent to 147.6 MMscfpd and 130.9 MMscfpd for the three and nine months ended September 30, 2019, versus 114.9 MMscfpd and 110.6 MMscfpd for the same periods in 2018, respectively. Total natural gas revenue, net of royalties and transportation expenses for the three and nine months ended September 30, 2019, grew 25 percent and 19 percent to $55.1 million and $148.2 million, versus $43.9 million and $125 million for same periods in 2018, respectively, primarily attributable to the growth of natural gas production.

For the rest of this year, Canacol Energy is concentrating on executing its exploration drilling program and executing the required agreements related to the construction of a new gas pipeline to Medellin, which will transport 100 MMcfpd of new gas sales in 2023. The 2019 drilling program has been successful so far, with two discoveries, Acordeon-1 and Ocarina-1, and three successful development wells, Palmer-2, Nelson-7, and Clarinete-4.

In addition, in November, Canacol Energy announced that started the production and sale of liquified natural gas (LNG), the first such operation in Colombia. Furthermore, the Company is in negotiation with Galileo Technologies to create a joint venture (JV) that will install terminals at other locations in Colombia and supply end user solutions with the aim to replace diesel, fuel oil, compressed natural gas, propane and other fuels with LNG. During 2019 Canacol Energy installed four natural gas liquefaction modules bought from Galileo at its primary gas processing facility at Jobo. These modules can convert 2.4 million standard cubic feet per day (MMscfpd) of gas into 29,000 gallons of LNG.

Canacol Energy Ltd. (CNNEF), closed Tuesday's trading session at $3.27, even for the day, on 14,200 volume. The average volume for the last 3 months is 24,614 and the stock's 52-week low/high is $2.63000011/$3.96000003.

chart

Crexendo, Inc. (CXDO)

NetworkNewsWire, Zacks, Investors Observer, Investor Village, Stockhouse, Seeking Alpha, Simply Wall St, Tip Ranks, MarketBeat, Wallet Investor, Barchart, Market Wire News, Trading View, YCharts, Market Screener, Capital Cube, InvestorsHub, Stockwatch, MarketWatch, Last10k, Wallmine, and 4-Traders reported beforehand on Crexendo, Inc. (CXDO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Crexendo, Inc. is an award-winning first-class provider of cloud communications, UCaaS (Unified Communications as a Service), call center, collaboration services for businesses, and other cloud business services. The design of these is to provide enterprise-class cloud services to any size business at affordable monthly rates. Crexendo is a full-service cloud communications provider. OTCQX-listed, Crexendo is based in Tempe, Arizona.

The Company delivers critical voice and data communication services to small, medium, and small enterprise markets. Its solutions include phones, mobile, cloud and call center. In addition, Crexendo’s solutions include collaboration, integrations, unified communications, and features. Important features for enhancing business communications and productivity include business dashboard, call recording, cloud communicator, SMS & Chat, and the aforementioned collaboration. Furthermore, important features include cloud fax, unified messaging, and full feature suites.

Crexendo's Cloud Communicator provides award winning UCaaS solutions. This allows businesses the ability to manage phone calls, text messages, conferences, voicemail, video, chat, CRM, and instant messaging within the Crexendo platform. Crexendo’s patented solutions include a comprehensive hosted phone system with enterprise-grade features, a user-friendly portal, and also strong mobile applications.

In November, Crexendo reported financial results for Q3 of 2019. Q3 financial highlights include Total Revenue increasing 19 percent year over year to $3.6 million. UCaaS Service Revenue rose 24 percent year over year to $3.1 million. GAAP Net Income was $334,000 or $0.02 per diluted share. Non-GAAP Net Income was $454,000 or $0.03 per diluted share.

Consolidated Total Revenue for the nine months ended September 30, 2019 rose 22 percent to $10.7 million versus $8.8 million for the nine months ended September 30, 2018. Consolidated Service Revenue for the nine months ended September 30, 2019 grew 22 percent to $9.4 million versus $7.7 million for the nine months ended September 30, 2018.

Yesterday, Crexendo announced that Mr. Doug Gaylor, the Company’s President and Chief Operating Officer and Mr. Ron Vincent, its Chief Financial Officer, will present Wednesday December 11, 2019 at 2:00 PM in Track 4 at the Luxe Sunset Boulevard Hotel in Los Angeles, California. Company Management will be available for one-on-one meetings. The LD Micro Main Event will take place on December 10-12, 2019 in Los Angeles at the Luxe Sunset Bel Air Hotel. The investor conference will feature 275 companies and be attended by more than 1,400 individuals.

Crexendo, Inc. (CXDO), closed Tuesday's trading session at $4.24, up 0.952381%, on 300 volume with 2 trades. The average volume for the last 3 months is 2,960 and the stock's 52-week low/high is $1.60000002/$4.40000009.

chart

MRI Interventions, Inc. (MRIC)

Zacks, EarningsCast, Investing.com, TipRanks, YCharts, Equity Clock, 4-Traders, Last10k, Street Insider, Market Screener, Wallet Investor, Stockhouse, InvestorsHub, Simply Wall St, Trading View, MarketBeat, Proactive Investors, and OTC Markets reported previously on MRI Interventions, Inc. (MRIC), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

MRI Interventions, Inc. creates innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain. A medical device enterprise, the Company develops and commercializes unique platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging, or MRI guidance. It is developing products designed for navigation, ablation, deep brain stimulation, biopsy, aspiration and gene therapy. MRI Interventions is headquartered in Irvine, California.

MRI Interventions has two product platforms: the ClearPoint® system and the ClearTrace system. Its ClearPoint® system is in commercial use. It is used to perform minimally invasive surgical procedures in the brain.

The ClearTrace system is still under development. It will be used to perform minimally invasive surgical procedures in the heart. Both systems use intra-procedural magnetic resonance imaging to guide the procedures. The design of both systems is to work in a hospital’s existing MRI suite.

MRI Intervention’s belief is that its ClearPoint system may enable physicians to treat patients who otherwise may not be treated using present surgical techniques. In addition, by providing direct, intra-procedural visualization, MRI believes its ClearPoint system could reduce the amount of time required to perform procedures and enable physicians to treat more patients in a given period of time.

MRI Interventions recently announced its financial results for its Q3 ended September 30, 2019. The Company increased revenue 62 percent year-over-year to a record $2.9 million. It supported a record 233 cases, versus 197 in the prior quarter and 175 in the 2018 Q3, a year-over-year growth of 33 percent.

MRI Interventions increased to 10 centers using the Company’s two cases per day protocol and also completed the 3,000th ClearPoint Neuro Navigation System case. Furthermore, it signed an additional product development agreement in the biologics and drug delivery space and shipped product or performed services for 15 programs during 2019.

Mr. Joe Burnett, President and Chief Executive Officer of MRI Interventions, said, “Based on our strong third quarter and year-to-date results combined with confidence in our anticipated fourth quarter sales, we are increasing our full-year 2019 revenue forecast to a range of $10.5 million to $11.5 million, from our previous forecast calling for a range of $10.0 million to $11.0 million.”

MRI Interventions, Inc. (MRIC), closed Tuesday's trading session at $3.88, off by 0.512821%, on 17,331 volume with 111 trades. The average volume for the last 3 months is 41,467 and the stock's 52-week low/high is $1.33000004/$5.86000013.

chart

North Bud Farms, Inc. (NOBDF)

CannabisMarketCap, Stock Day Media, Investors Observer, TradingView, GuruFocus, Nasdaq, Morningstar, BioSpace, InvestorX, Wallet Investor, Market Screener, Otc.watch, Seeking Alpha, GlobeNewswire, Stockhouse, Dividend Investor, Investors Hangout, OTC Markets, Proactive Investors, and InvestorsHub reported earlier on North Bud Farms, Inc. (NOBDF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

North Bud Farms, Inc., via its wholly-owned subsidiary, GrowPros MMP, Inc., is pursuing a license under The Cannabis Act. The Company has built a state-of-the-art purpose-built cannabis production facility on 135 acres of Agricultural Land in Low, Quebec. North Bud, via its wholly-owned U.S. subsidiary, Bonfire Brands USA, has acquired cannabis production facilities in California and Nevada. North Bud Farms lists on the OTC Markets Group’s OTCQB. Incorporated in 2016, the Company is headquartered in Toronto, Ontario.

The Salinas, California property is situated on 11 acres that presently comprises 300,000 sq. ft. of licensable greenhouse space with 60,000 sq. ft. actively cultivating cannabis and a 2,000 sq. ft. building licensed for distribution. The Reno, Nevada property is situated on 3.2 acres of land that was acquired via the acquisition of Nevada Botanical Science, Inc. a premier cannabis production, research and development (R&D) facility with 5,000 sq. ft. of indoor cultivation that holds medical and adult use licenses for cultivation, extraction and distribution.

Regarding the Low, Quebec cannabis production facility, upon being fully licensed, North Bud Farms’ facility will produce craft cannabis indoors and farm acres of extraction-grade cannabis outdoors. Further to cultivating outdoors, the Company’s Quebec facility is powered by a sustainable and cost-efficient energy source.

In November, North Bud Farms announced that Bonfire Brands USA, its wholly-owned subsidiary, signed a definitive asset purchase agreement to acquire all the assets of Nevada Botanical Science, Inc. (NBS – Reno, Nevada) in a transaction valued at USD$7.5 million. NBS holds Nevada State medical and adult use licenses for cultivation, extraction and distribution.

In addition, in November, North Bud Farms announced that Bonfire Brands USA signed numerous definitive agreements related to its earlier announced Letters of Intent (LOI) with the Qlora Group and Monterey Holdings. Bonfire Brands USA finalized the acquisition of an 11-acre property at 20180 Spence Road Salinas, California from Monterey Holdings, Inc. At present, the property comprises 300,000 sq. ft. of licensable greenhouse space with 60,000 sq. ft. actively cultivating cannabis and a 2,000 sq. ft. building licensed for distribution.

Moreover, Bonfire Brands USA signed a definitive agreement with the Qlora Group for the acquisition of cultivation, processing and distribution licenses associated to the Spence Road property. As part of the acquisition, Bonfire Brands USA also acquires all the Intellectual Property (IP) and assets related to the brands California Bud Co and Live For The Day (LFTD).

North Bud Farms, Inc. (NOBDF), closed Tuesday's trading session at $0.138, even for the day, on 1,000 volume with 2 trades. The average volume for the last 3 months is 5,131 and the stock's 52-week low/high is $0.1268/$0.370000004.

chart

Sailfish Royalty Corp. (SROYF)

Streetwise Reports, TipRanks, Investor Observer, OTC Markets, Metals News, Lamp News, GuruFocus, Morningstar, Investors Hangout, Otc.watch, Nasdaq, Wallet Investor, Gold Stock Data, Dividend.com, MarketWatch, Dividend Investor, GlobeNewswire, Market Screener, Stockhouse, and Seeking Alpha reported earlier on Sailfish Royalty Corp. (SROYF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Based in Tortola, British Virgin Islands, Sailfish Royalty Corp. is a precious metals royalty and streaming company. Its intention is to aggressively grow its portfolio and become a yield-focused enterprise by paying dividends to its shareholders. The Company is backed by Wexford Capital LP, which is a well-funded investor that was part of the creation of Viper Energy Partners LP (Nasdaq:VNOM), a foremost energy royalty company with a US$4.1 billion market cap. Sailfish has the ability to invest internationally, with an emphasis on the Americas. Sailfish Royalty’s shares trade on the OTC Markets Group’s OTCQX.

Fundamentally, Sailfish Royalty has a clear-cut business model, in exchange for an upfront payment the Company receives the right to purchase a portion of the gold and/or silver produced from a mine at a fixed price or discount to spot. The Company receives a portion of the revenue produced from a mine. Sailfish Royalty sells the metal at spot and roughly 90 percent of cash flow is expected to be distributed to shareholders.

Within the Company’s portfolio are two cornerstone assets on advanced stage projects in the Americas. One is a gold stream equivalent to a 3 percent NSR on the San Albino gold project (approximately 3.5 sq. km) - mine type: open pit gold mine, followed by underground. The other is a 2 percent NSR on the rest of the area (approximately 134.5 sq. km) surrounding San Albino in northern Nicaragua. Sailfish Royalty also has an up to 3.5 percent NSR on the Tocantinzinho gold project in the prolific Tapajos district of northern Brazil – mine type: open pit/flotation CIP.

Sailfish closed the acquisition of Terraco Gold Corp. in August of this year. This adds a potential cornerstone asset to the portfolio - an up to 3% NSR on the multi-million ounce Spring Valley gold project in Pershing County, Nevada. Moreover, the Company completed the San Albino gold stream restructuring in November of 2018. This eliminated all funding commitments, fast tracked the timeline to cash flow, added additional assets (including cash), and provides more exposure to a highly prospective gold district in Nicaragua.

Sailfish Royalty Corp. (SROYF), closed Tuesday's trading session at $0.5941, off by 1.7286%, on 227,900 volume with 44 trades. The average volume for the last 3 months is 28,064 and the stock's 52-week low/high is $0.423999994/$1.32000005.

chart

TerraX Minerals, Inc. (TRXXF)

Northern Miner, Resource World, GuruFocus, Junior Ming Network, MarketWatch, Seeking Alpha, Market Screener, TradingView, Nasdaq, Stockhouse, Canadian Insider, Dividend Investor, Wallet Investor, Morningstar, and Proactive Investors reported beforehand on TerraX Minerals, Inc. (TRXXF), we report on the Company as well, here at the QualityStocks Daily Newsletter.

TerraX Minerals, Inc. is a junior gold exploration company listed on the OTC Markets. Via a series of acquisitions, TerraX owns a 100 percent interest in the Yellowknife City Gold (YCG) Project, covering 783 sq. km of contiguous land within 12 kilometers of the City of Yellowknife. The Company previously went by the name TerraX Resource Corp. It changed its name to TerraX Minerals, Inc. in March of 2008. Incorporated in 2007, TerraX Minerals is based in Vancouver, British Columbia.

The YCG Project is positioned in the prolific Yellowknife greenstone belt, encompassing 70 kilometers of strike length along the chief mineralized break in proximity to the former high-grade Con and Giant gold mines that have produced more than 14 million ounces of gold. The YCG Project is close to essential infrastructure. This includes all-season roads, air transportation, service providers, hydro-electric power, as well as skilled tradespeople.

The Yellowknife Gold Belt is recognized as one of the major Archean gold belts in Canada. It has equivalent geology and deposit types to other major gold camps such as Timmins (Destor-Porcupine Break) and Val-d'Or (Cadillac-Larder Break). The Yellowknife Gold Belt has produced greater than 15 million ounces of gold.

Last month, TerraX Minerals announced a first mineral resource estimate on its 100 percent owned Yellowknife City Gold (YCG) Project. The classification of the mineral resource estimate was completed in accordance with the Canadian Institute of Mining, Metallurgy and Petroleum (CIM) Definition Standards incorporated by reference in National Instrument 43-101 (NI 43-101).

The Inferred resource estimate of 735,000 ounces consists of a pit constrained Inferred resource of 11.6 million tonnes averaging 1.4 g/t for 523,000 ounces of contained gold and an underground Inferred resource of 1.2 million tonnes averaging 5.7 g/t for 212,000 ounces of contained gold.

Yesterday, TerraX Minerals announced that it filed a technical report prepared in accordance with National Instrument 43-101 - Standards of Disclosure for Mineral Projects supporting the first mineral resource estimate on its Yellowknife City Gold (YCG) Project, as reported in its news release dated November 4, 2019. The technical report, titled "Technical Report on the Resource Estimates for the Crestaurum-Barney-Sam Otto/Mispickel Deposits, Yellowknife City Gold Project, Yellowknife, Northwest Territories, Canada," is dated December 2, 2019 with an effective date of November 4, 2019.

TerraX Minerals, Inc. (TRXXF), closed Tuesday's trading session at $0.211, up 4.9751%, on 17,000 volume with 3 trades. The average volume for the last 3 months is 13,935 and the stock's 52-week low/high is $0.167999997/$0.364300012.

chart

ProtoKinetix, Incorporated (PKTX)

Investor Village, ResearchPool, OTC PR Group, Stockwatch, Trading View, 4-Traders, Wallet Investor, and Allstocks reported earlier on ProtoKinetix, Incorporated (PKTX), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

A molecular biotechnology company, ProtoKinetix, Incorporated provides medical researchers with a platform for enhancing cell survival and health, in vitro and in vivo. The Company has developed and patented a family of hyper stable, potent glycopeptides (AAGP®) that enhance engraftment and protection of transplanted cells, organs, tissues and organs used in regenerative medicine. ProtoKinetix is based in Marietta, Ohio.

At the core of the Company’s technology is its patented anti-aging glycopeptide AAGP™. This small molecule (580 Daltons) displays abilities in resolving challenges facing medical researchers in areas such as regenerative medicine and as a therapy for diseases relating to tissue inflammation and oxidation stress. Due to its stability, small size and molecular makeup, it maintains its function in vivo without triggering the body's immune system. In addition, it can function without toxic side effects common in treatments involving larger and less stable compounds. AAGP™ is manufactured at facilities in North America, Europe, and Asia for shipment around the world.

ProtoKinetix is building value via the independent research of laboratories, university and private, into applications for its AAGP™ molecule. Regarding health solutions, there are two chief categories that AAGP™ applications would be divided into. One is regenerative Medicine issues. This includes harvesting, processing, storage and transplanting cells, tissues and organs. The other is treatments for chronic inflammatory conditions and diseases caused by stress factors. This includes UV radiation, oxidation, and cryopreservation and hydrogen cyanide.

Because of the results attained over the last four years of testing, the University of Alberta has started Phase 1 human clinical trials. Additional studies will be expanded to include whole organ transplantation and all therapies that are being developed worldwide to date; diabetes, retinal degeneration, cardiac repair and many other degenerative conditions. ProtoKinetix is also studying the potential impact on a number of cancer therapies.

Recently, ProtoKinetix announced that it secured a partnership agreement with IMPART investigator team Canada at Dalhousie University. It has now started studies to reveal the benefits of PKX-001 (AAGP®) in cardiac metabolism. The studies will determine the efficacy of PKX-001 as a cardioprotectant and will be led by Diabetes Canada Scholar, Dr. Thomas Pulinilkunnil.

ProtoKinetix also recently announced reaching the midpoint of a Phase-1 first-in-human clinical trial of AAGP® PKX-001 treated islet cells used in conjunction with the Edmonton Protocol for the treatment of Type-1 diabetes. All six patients were recruited and treated under this protocol. All primary safety goals were achieved at the midpoint in all study participants. As such, the protocol will now be amended to increase the number of participants in the trial with additional secondary goals added. This includes dose escalation to establish optimization criteria for efficacy testing.

ProtoKinetix, Incorporated (PKTX), closed Tuesday's trading session at $0.1295, up 32.8205%, on 24,997 volume with 6 trades. The average volume for the last 3 months is 97,663 and the stock's 52-week low/high is $0.05/$0.319999992.

chart

Blue Line Protection Group, Inc. (BLPG)

Penny Stock Tweets, Stockwolf, Marketwired, YCharts, Capital Cube, Awesome Penny Stocks, Barchart, New Cannabis Ventures, Marijuana Stocks, Cannabiznetwork, and Dividend Investor reported earlier on Blue Line Protection Group, Inc. (BLPG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Blue Line Protection Group, Inc. provides consulting, armed security, compliance and investigations, transportation, and secure vaulting services to banks, businesses and government entities. The Company’s professional team consists chiefly of former military and law enforcement personnel with decades of experience in protection, investigations, logistics, and tactical industries. Blue Line Protection Group is based in Denver, Colorado and lists on the OTC Markets.

The Company works side-by-side with retail establishments. It lessens the risk of criminal activity and creates a secure retail experience through protecting businesses on-site and securing their assets on the road.

Blue Line helps retailers remain compliant with all applicable laws. Furthermore, it shows retail establishments how to protect their businesses through letting Blue Line assume the responsibility and liability for their protective services.

The Company serves banks and credit unions through providing currency processing and transportation solutions. Its risk mitigation services help financial institutions serving cash-intensive industries comply with federal “know your customer” mandates. Blue Line Protection Group announced in October of 2018 that its Cash In Transit (CIT) operations, including vaulting, processing, and tactical compliance, is now available in Arizona.

Blue Line acts on behalf of banks and credit unions through collecting cash sales revenue from their client locations. Upon collecting the currency, the Company transports it to one of its secure processing facilities. Blue Line provides currency handling and validation services for the bank and transportation of processed currency to the Federal Reserve.

Blue Line Protection Group and Hypur have plans to open a cash vaulting and processing facility. This is to serve marijuana-related businesses (MRBs) and cash-intensive businesses (CIBs) in Nevada. Blue Line plans to partner with Hypur to expand services to Arizona, Oregon, Washington, California and Nevada. Hypur is a financial technology company based in Scottsdale, Arizona. The new Nevada facility will implement “Hypur Vault” cash management technologies.

Blue Line Protection Group’s Professional Affiliations include National Cannabis Industry Association, ASIS International, Marijuana Industry Group, Society of Corporate Compliance and Ethics, and Marijuana Business Association. Its Professional Affiliations also include International Association of Chiefs of Police, Professional Private Investigators Assn of Colorado, and Society for Human Resources Management.

Blue Line Protection Group, Inc. (BLPG), closed Tuesday's trading session at $0.00046, up 53.3333%, on 3,896,195 volume with 205 trades. The average volume for the last 3 months is 4,458,370 and the stock's 52-week low/high is $0.0003/$0.0043.

chart

Dakota Territory Resource Corp. (DTRC)

InvestorsHub, Zacks, Market Screener, YCharts, TradingView, Stockhouse, Barchart, Simply Wall St, Uptick Newswire, Real Investment Advice, Innovative Marketing, OTC Markets Group, Ultimate Penny Stock, MarketWatch, The Street, Marketbeat, Dividend Investor, last19k, Wallet Investor, Corporate Information, and 4-Traders reported earlier on Dakota Territory Resource Corp. (DTRC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Dakota Territory Resource Corp.’s emphasis is on the acquisition and responsible exploration and development of high caliber gold properties in the Black Hills of South Dakota. The Company maintains 100 percent ownership of three gold properties encompassing roughly 4,059 acres. These include the Blind Gold, City Creek, and Homestake Paleoplacer Properties. All of these properties are in the heart of the Homestake District. OTCQB-listed, Dakota Territory Resource is headquartered in Reno, Nevada.

The Company’s flagship property is the Blind Gold Property, which is a target for Tertiary-aged and Iron-formation gold mineralization. The Blind Gold Property is about four miles northwest and on structural trend with the historic Homestake Gold Mine.

The Homestake Gold Mine produced roughly 40 million ounces of gold through its 125-year production history. It is the largest iron-formation-hosted gold deposit in the world.

Dakota Territory’s plan is to continue its sampling program along trend of the zone of high grade gold mineralization identified by the first pass surface sampling program conducted on its 100 percent owned Blind Gold Property. The program identified a zone of high-grade gold mineralization in the Mississippian-age Pahasapa Limestone on the surface, with a peak gold assay value of 9.44 grams per tonne.

The Homestake Paleoplacer Property consists of 13 unpatented lode mining claims. These are situated one-mile north of the Homestake Open Cut. Dakota based the acquisition of its Black Hills property position on more than 44 years of combined mining and exploration experience in the Homestake District.

The Company’s City Creek Property is a target for Homestake iron-formation gold mineralization. City Creek consists of 21 unpatented lode mining claims. These are positioned one-mile northeast of the Homestake Open Cut and one-mile northwest of the City of Deadwood.

Recently, Dakota Territory Resource announced the appointment of Mr. Lee Graber to the Company’s Strategic Advisory Committee. Mr. Graber has more than four decades of experience in the mining industry. This includes 23 years with Homestake Mining Company, one of the largest gold mining companies in the U.S. until it was acquired in 2002 by Barrick Gold Corporation.

As Homestake's Vice President responsible for corporate development, Mr. Graber initiated, managed, and closed manifold joint venture agreements, major acquisitions, and divestment transactions. After Homestake, Mr. Graber served as Managing Director, Mergers and Acquisitions, for Endeavour Financial Ltd.

Dakota Territory Resource Corp. (DTRC), closed Tuesday's trading session at $0.088, up 25.7143%, on 1,000 volume with 2 trades. The average volume for the last 3 months is 10,160 and the stock's 52-week low/high is $0.019999999/$0.191750004.

chart

RespireRx Pharmaceuticals, Inc. (RSPI)

NetworkNewsWire, Penny Stock Tweets, Infront Analytics, Stockflare, Barchart, InvestorsHub, Stockopedia, Penny Stock Hub, Wallet Investor, Simply Wall St, Marketbeat, YCharts, Street Insider, Marketwired, Stockhouse, Daily Marijuana Observer, last10k, Investors Hangout, GuruFocus, MarketWatch, Stockwatch, 4-Traders, and Real Investment Advice reported earlier on RespireRx Pharmaceuticals, Inc. (RSPI), and today we report on the Company, here at the QualityStocks Daily Newsletter.

RespireRx Pharmaceuticals, Inc. is a leader in the development of medicines for respiratory disorders and CNS indications, with a concentration on obstructive sleep apnea, attention deficit hyperactivity disorder (ADHD), spinal cord injury, other neurological conditions and drug-induced respiratory depression. RespireRx Pharmaceuticals has its corporate office in Glen Rock, New Jersey. The Company lists on the OTC Markets Group’s OTCQB.

RespireRx has filed over 400 patents in the U.S. and offshore that claim composition of matter, use, formulation, dosage, as well as mechanism of action. Use claims include treating sleep apnea and preventing or rescuing drug-induced respiratory depression, and also for improving memory and cognition, treating schizophrenia and other central nervous system (CNS) indications.    

  The Company’s pharmaceutical candidates in development are derived from two platforms. One platform is the class of compounds called cannabinoids. This includes, in particular, Dronabinol. Dronabinol (D9-THC, D9-tetrahydrocannabinol) is an oral capsule drug product. Dronabinol (D9-THC) is a generic, orally active cannabinoid. It is undergoing testing for clinical efficacy in patients with obstructive sleep apnea (OSA).

RespireRx Pharmaceuticals (under a license agreement with the University of Illinois) has rights to patents claiming the use of cannabinoids for the treatment of sleep-related breathing disorders. Two Phase 2 clinical trials have been completed. Both have demonstrated substantial reductions in sleep apnea produced by dronabinol. 

Dronabinol is Food and Drug Administration (FDA) approved for the treatment of anorexia in AIDS patients and nausea and vomiting in cancer patients undergoing chemotherapy (Marinol®). It is a Schedule III drug available by prescription, with a low risk of addiction.

The other platform of medicines undergoing development by RespireRx is a class of proprietary compounds called ampakines. These act to enhance the actions of the excitatory neurotransmitter glutamate at AMPA glutamate receptor sites in the brain. Several ampakines, in oral and injectable form, are undergoing development by RespireRx for the treatment of an assortment of breathing disorders.

Recently, RespireRx Pharmaceuticals announcd the promotion of Mr. James Sapirstein to Executive Vice Chairman of the Board of Directors effective December 28, 2018. Mr. Sapirstein has served as a member of the Board of Directors since 2014. He expands his role within RespireRx Pharmaceuticals to assist with business development and fundraising activities to advance the development of the Company’s pipeline of neuromodulators with an emphasis on sleep apnea and neurologic and psychiatric disorders.

Mr. Sapirstein is a highly-regarded pharmaceutical industry executive. He has more than 35 years of success in building companies and leading the commercial launch of almost two dozen prescription drugs in the fields of CNS, infectious disease, and cancer. Mr. Sapirstein has worked at major pharmaceutical companies, Bristol-Myers Squibb, Hoffmann-LaRoche and Eli Lilly. He has also led commercial teams for biotechnology companies including Gilead Sciences and Serono Laboratories.

RespireRx Pharmaceuticals, Inc. (RSPI), closed Tuesday's trading session at $0.2349, up 50.964%, on 615 volume with 3 trades. The average volume for the last 3 months is 2,604 and the stock's 52-week low/high is $0.155599996/$1.02499997.

chart

MoneyOnMobile, Inc. (MOMT)

Stockflare, Marketwired, Stockopedia, Barchart, The Street, TradingView, YCharts, 4-Traders, OTC Markets, MarketWatch, InvestorsHub, and Morningstar reported on MoneyOnMobile, Inc. (MOMT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, MoneyOnMobile, Inc. is one of India's largest mobile phone-based payment networks. The Company facilitates easy, safe, and secure financial transactions to millions of Indians. Its core belief is in providing service to the unbanked consumer, by way of Financial Inclusion and self-dependence.

The Company previously went by the name Calpian, Inc. It changed its corporate name to MoneyOnMobile, Inc. in August 2016. Incorporated in 2006, MoneyOnMobile has offices in Dallas, Texas, and Mumbai, India.

The Company’s services include money transfer, mobile recharge, bill payment, DTH recharge, train tickets, flight tickets, hotel booking, and online shopping. It designed MoneyOnMobile to work across all mobile phone handsets. This is from the most basic to the most advanced.

MoneyOnMobile continually innovates to provide a range of innovative solutions together with its continuous, premier, 24 x 7 transactional convenience via a simple SMS, Application and Web Portal.  

MoneyOnMobile has authorization by the Reserve Bank of India (RBI) to set up a semi-closed payment system in India. This system enables registered users to buy goods, products, and services from registered Merchants.  MoneyOnMobile provides a broad array of services on a real-time basis, irrespective of geography, time, and mobile operator.

MoneyOnMobile announced in June the launch of the Reserve Bank of India's payment service (Bharat Billpay) through the MoneyOnMobile retailer platform. The launch of the new service enables its retailers to meet the growing demand for digital payment services among the estimated 600-800 million unbanked/underbanked population of India and increase the monthly spend of its existing customers.

Recently, MoneyOnMobile announced the number of MOM ATM units deployed in India has surpassed the 10,000-unit mark. Mr. Harold Montgomery, MoneyOnMobile’s Chairman and Chief Executive Officer, said, "We are pleased with the progress of our MOM ATM deployments. Crossing the 10,000-unit mark demonstrates, we believe, strong demand for this product by our retailers. We are well on our way to reaching our goal of 30,000 MOM ATM units deployed by the end of 2019. This is the first step in the cycle of deployment activation and revenues.”

MoneyOnMobile, Inc. (MOMT), closed Tuesday's trading session at $0.0656, up 320.5128%, on 1,071 volume with 5 trades. The average volume for the last 3 months is 640 and the stock's 52-week low/high is $0.014999999/$0.430000007.

chart

SpendSmart Networks, Inc. (SSPC)

Marketbeat.com and Flagler Financial Group reported on SpendSmart Networks, Inc. (SSPC), and we also report on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, SpendSmart Networks, Inc. does business as (d/b/a) SMS Masterminds (SMS). The Company provides proprietary loyalty systems and a collection of digital engagement and marketing services. These help local merchants build relationships with consumers and grow revenues. The Company formerly went by the name The SpendSmart Payments Company, Inc. It changed its name to SpendSmart Networks, Inc. in June 2014. SpendSmart Networks has its headquarters in San Luis Obispo, California.

At present, the Company delivers and manages loyalty platforms. These include merchant funded rewards; loyalty rewards tablet/kiosk, as well as proprietary rewards management systems. In addition, it delivers and manages mobile marketing technology. This includes text and email messaging, customer analytics and propensity marketing, patent pending automated engagement engine, and Text2Win sweepstakes features.

SpendSmart Networks is a specialist in Mobile. It assists local businesses in finding new customers, and turn existing customers into digital advocates. The Company will optimize a client’s website, produce more reviews, and get a client’s customers to return more frequently via SpendSmart’s loyalty and text message marketing strategies.

Furthermore, SpendSmart Networks delivers and manages enterprise level loyalty and mobile marketing consulting. This consists of monthly hands on reviews by its Certified Masterminds, campaign creation and optimization, and localized support.

The Company also provides mobile and loyalty marketing services for small and medium sized businesses. Additionally, it provides personalized Website, e-commerce, and mobile application (app) development services; and Web marketing tools and analytics.

Consumers' dollars go further when they spend it with merchants in the SpendSmart network of merchants. This is because they receive exclusive deals, earn rewards, and in due time build a connection with their favorite merchants.

SpendSmart Networks services are implemented and supported by an extensive network of certified digital marketing specialists (Certified Masterminds) who grow revenue and consumer relationships for merchants through loyalty programs, mobile marketing, and website development.

In October of 2017, SpendSmart Networks announced that it entered into a purchase agreement to sell its operational assets to Eclipse Marketing, LLC. The sale will permit the Company to decrease its ongoing monthly expenses and also improve its debt structure.

After this transaction, SpendSmart Networks’ intention is to find an existing private company to merge into its public entity.

Mr. Luke Wallace, SpendSmart Networks’ Chief Executive Officer, said in October, "This transaction provides the company with its best opportunity to clean its balance sheet and merge with a new company that has a strong potential for growth."

SpendSmart Networks, Inc. (SSPC), closed Tuesday's trading session at $0.0002, up 100.00%, on 65,000 volume with 1 trade. The stock's 52-week low/high is $0.000000999/$0.007199999.

chart

Sauer Energy, Inc. (SENY)

Winston Small Cap, Shiznit Stocks, PennyStocks24, Fast Money Alerts, Penny Stock General, RockingPennyStocks, StockHideout, Investment U, DSR News, The Next Big Trade, Penny Stock Hub, BestDamnPennyStocks, and Stock Shock and Awe reported previously on Sauer Energy, Inc. (SENY), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Sauer Energy, Inc. is a technology developer and manufacturer. The Company is concentrating on the developing renewable energy market. It is the developer of the patented WindCharger™ brand vertical axis wind turbine (VAWT) and the manufacturer of the patented HelixWind® vertical axis wind turbine. Sauer Energy is uniting wind, solar, and storage together in harmony so that energy can be harnessed and processed to the greatest advantage. Sauer Energy’s head office and manufacturing facility is in Oxnard, California.

The Company is addressing worldwide energy through developing complete renewables packages by way of three energy sources that can help ensure the optimization of opportunities to capture the elements and produce electricity quicker, simultaneously, and individually. It created the WindCharger™ model to provide a better solution for the use of wind capture for residential or small building use. The WindCharger™ is one of its vital innovation priorities. Sauer Energy has several patents in place and more pending.

The design of Helix vertical axis wind turbine systems is purposely to be pole mounted and can respond to the demand for applications that do not necessitate roof mounting. Sauer’s technology requires few parts. Therefore, it provides a new direction for wind capture, scales easily from residential to small community and up to large industrial scale.

Sauer and Helix turbines underwent development to produce a quiet and low-impact technology with a high output of sustainable renewable energy. The focus of the WindCharger™ and Helix turbines has centered on patented disruptive technology, minimum impact on the environment, mounting flexibility, and versatility with highly efficient output.

The Company’s WindRider® turbine has a new mount and its own proprietary system for on-grid or off-grid structures. The Company’s intention is to offer the patented helixical WindRider® model vertical axis wind turbine that uses the HelixWind technology.

Sauer’s WindCutter turbine is a very powerful Darrieus design. The WindCutter has five airfoil blades that use the principle of lift to rotate the shaft. It is pole mounted. The Company’s WindCutter 2.5, VAWT design is the first model cleared for launch.

This past October, Sauer Energy had on view its WindCutter™ turbine solution at the Willow Springs International Motorsports Raceway, in Rosamond, California. With the installation completed and on display anyone could witness the WindCutter in operation as it produced power. The Company’s aim is to always improve technological advancements through finding new ways to make power more efficiently.

Mr. Dieter Sauer, Sauer Energy’s Chief Executive Officer and President said in late October, “What a milestone achievement for the SEI team as we enter a new chapter in our history.”

Sauer Energy, Inc. (SENY), closed Tuesday's trading session at $0.0053, up 51.4286%, on 68,242 volume with 7 trades. The average volume for the last 3 months is 72,631 and the stock's 52-week low/high is $0.0006/$0.017899999.

chart

The QualityStocks Company Corner

Sigma Labs Inc. (NASDAQ: SGLB)

The QualityStocks Daily Newsletter would like to spotlight Sigma Labs Inc. (SGLB).

Sigma Labs Inc. (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D-printing industry, announced that it has been awarded a Phase 2 rapid test and evaluation (RTE) contract by a leading global energy technology company. This final phase of an RTE contract is required to enable end-users to make a purchase decision on deploying Sigma’s technology in serial production (http://nnw.fm/ft3Bm). Also today, NetworkNewsWire released a report on the company detailing how additive manufacturing, better known as three-dimensional or 3D printing, has potential to change the world. However, the full promise of the technology has been stymied due to the high costs and complexities of end-product inspection and quality control. With its pioneering PrintRite3D(R) software, Sigma Labs Inc. (NASDAQ: SGLB) (SGLB Profile) appears to be ready to help unleash the transformative forces of 3D printing and usher in what’s been called the fourth industrial revolution.

Sigma Labs Inc. (SGLB) is the only provider of in-process quality-assurance software to the commercial 3D printing metal industry that enables operators of machines making 3D metal parts to offset emerging quality problems, sustain part quality, and avoid rejects. Sigma’s software is the singular solution that enables both real-time, in-process detection of quality control manufacturing irregularities for critical metal parts and then provides the operator the actionable information needed to adjust and mitigate the developing anomaly. Sigma Labs’ software represents a paradigm shift in the quality control process for the manufacture of 3D printed metal components. The nascent 3D metal printing industry is on the verge of radically altering the speed and technical complexity of manufactured parts. Further, it makes possible just-in-time availability of critical components – all at reduced cost, time, waste and weight. 3D printing, heralded as the fourth industrial revolution in manufacturing, will only truly surpass traditional techniques when the additive manufacturing industry moves from “post process” quality control to “in process” quality assurance.

For the industry to move from prototype manufacturing of critical components to economically viable commercial production, the 3D metal printing industry must find ways to dramatically increase production speed and quality yields, and to dramatically decrease the excessive cost of quality control. To achieve these prerequisites and move 3D metal printing into the mainstream, parts must be inspected and certified during the manufacturing process rather than after. Parts in the production process that are developing signs of quality control problems must be identified in real-time and alerts must be issued. The problem, along with the solution, must then be communicated to the machine operator to implement repairs.

Revolutionizing Additive Manufacturing

Sigma Labs, with its PrintRite3D® brand, has established a new benchmark in the development and commercialization of real-time computer aided inspection (“CAI”) solutions. Sigma Labs resolves the major roadblocks and costly quality control challenges that impede the 3D manufacture of precision metal parts. The company’s breakthrough computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance during production, uniquely allowing errors to be corrected in real-time.

Sigma Labs was founded in 2010 by a team of Los Alamos National Labs scientists and engineers to develop and commercially license advanced metallurgical products for the military ordinance, dental implants, and then for additive manufacturing (3D printing). After assessing 3D metal printing technology and the costly, inconsistent quality control issues, Sigma Labs concluded that the enormous potential of 3D metal printing could only scale up if in-process quality-assurance tools were developed to observe, manage and control the manufacturing complexities in such a manner that reliability and repeatability of very high precision quality metal parts could be achieved in the process. Sigma Labs’ patented and third-party validated software has achieved these objectives and now delivers the critical elements needed to unleash the promise of 3D metal printing.

Sigma Labs’ products and services are engineered, manufactured and qualified for use in the highly demanding and hyper precise production environments of the aerospace, defense, transportation, oil and gas, biomedical and other precision-dependent industries.

The Challenge

Additive metal manufacturing combines multiple processes and parts into one single 3D printed part. Due to variances in the additive manufacturing process, parts of consistent quality currently can’t be reliably produced in either large or small quantities without substantial postproduction inspection and rejection costs. Parts are inspected after production using CT scans and other means, so the manufacturer doesn’t know until the very end which of the finished parts meet design specifications. This means lost time, lost profits and inability to economically scale up production.

Innovative Approach

Sigma Labs solves this problem with its patented, in-process quality control technology that informs operators and engineers how to improve both the manufacturing process and quality by capturing meaningful data about inconsistencies in real-time. Sigma Labs is also partnering with OEMs, working toward the visionary introduction of revolutionary closed-loop control that will bypass the machine operator and automatically make in process corrections by reducing machine variations.

Sigma Labs’ next generation technology gives manufacturers the ability to make fast, virtual real-time adjustments so that each finished part is uniform and within critical specifications, thereby improving production quality, decreasing end-users’ risks and waste, and increasing profits and speed to market. Sigma Labs’ PrintRite3D® IPQA Software monitors and assesses the quality of each production part in the 3D additive manufacturing process – layer by layer, and in real-time. This has never been available until now.

Sigma Labs maintains a strong intellectual property portfolio consisting of trade secrets, process know-how and 34 patents either granted, pending or awaiting pre-publication around the globe. These patents encompass the fundamental technologies underlying Sigma Labs’ melt pool process control, data analytics, anomaly detection, signature identification, and future “closed-loop control” of 3D metal printing.

Market Opportunity

Providing advanced quality assurance software to the commercial 3D printing industry is currently a $1.4 billion addressable market expected to grow to $3.9 billion by 2023. Integrating Sigma Labs’ groundbreaking software helps arm the industry with a necessary catalyst to help enable and optimize the fourth industrial revolution in manufacturing.

Sigma Labs’ global client base includes 23 installations across 19 different users. Tier-1 OEM enterprises and end-users such as Siemens, Honeywell, Pratt & Whitney and others are currently evaluating PrintRite3D® for production lines.

Management Team

John Rice, CEO and chairman of the board of directors, has extensive experience as a CEO, lead negotiator, turnaround expert, business financier and crisis management executive/consultant. Prior to becoming chair and CEO of Sigma Labs, he was the CEO of a successful turn-around of a Coca-Cola Bottling Company. Rice has led a variety of companies in diverse business sectors and worked on a host of products and technologies including design and manufacture of high-end jet engine test equipment for the U.S. Airforce, chaff dispensers for F16s, software for modeling naval exercises, software for controlling warehouse distribution systems, medical radioisotopes, cancer detection, and cybersecurity. He is an honor’s graduate of Harvard College.

Darren Beckett, CTO, has over 20 years of experience in the semiconductor industry, including Intel Corporation, where he held various technical and managerial positions. His expertise in process engineering for advanced manufacturing technology includes statistical process control for fabrication of semiconductor devices.

CFO Frank D. Orzechowski also serves as treasurer, principal accounting officer, principal financial officer and corporate secretary. He has more than 30 years of distinguished financial and operational experience. Orzechowski began his career at Coopers & Lybrand in 1982, received his CPA certification in 1984, and received his Bachelor of Science in Business Administration with a major in accounting from Georgetown University in 1982.

Ronald Fisher, vice president of business development, is leading the commercialization of PrintRite3D® 5.0. Fisher is a mechanical engineer with hands-on experience in quality, manufacturing and product development. He has distinguished himself as a lead sales and marketing officer as well as a chief operating officer most recently before joining Sigma in technology startup that grew from market entry to successful exit by merger-acquisition.

Sigma Labs Inc. (SGLB), closed Tuesday's trading session at $1.12, up 16.4241%, on 544,503 volume with 1,193 trades. The average volume for the last 3 months is 180,887 and the stock's 52-week low/high is $0.451099991/$2.46000003.

Recent News

chart

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

Genprex Inc. (NASDAQ: GNPX) was highlighted today in a publication from Channelchek, examining how gene therapy is a biological product that mediates its effect by transcription and/or translation of transferred genetic material by integrating into the host genome. It is administered as nucleic acids, viruses, or genetically engineered microorganisms.

Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (NASDAQ: GNPX), closed Tuesday's trading session at $0.2908, up 2.0351%, on 489,990 volume with 846 trades. The average volume for the last 3 months is 180,887 and the stock's 52-week low/high is $0.240299999/$2.25999999.

Recent News

chart

LiveWire Ergogenics Inc. (OTC: LVVV)

The QualityStocks Daily Newsletter would like to spotlight LiveWire Ergogenics Inc. (LVVV).

LiveWire Ergogenics Inc. (OTC: LVVV) is an innovative company in the health and wellness industry that focuses on identifying and monetizing trends through special-purpose real-estate acquisitions. The Anaheim, California-based company is gaining traction in the cannabis industry with its foundational emphasis on ‘doing it right’ (http://cnw.fm/8Pgqi).

LiveWire Ergogenics Inc. (OTC: LVVV) is a forward-thinking company specializing in identifying and monetizing current and future trends in the health and wellness industry. The company recognizes significant potential in the multibillion-dollar cannabis industry and operates at the forefront for acquisition and management of licensed cannabis real estate locations and the research, development and commercialization of high-end products for distribution throughout California.

During the past two years, LiveWire has diligently researched, secured, designed and set up several fully compliant and permitted cannabis operations in locations in California, including a state-wide distribution license from the Bureau of Cannabis Control. The company is focused on acquiring compliant real estate properties for cannabis operations and entering into operation agreements and strategic alliances to build teams of carefully selected and vetted operators, horticulturists, extractors, distributors and establish research partnerships. Its current portfolio of cannabis operations consists of the following properties:

PODs and Distribution in Coachella, California

For the past year, LiveWire has operated high-tech, state-of-the-art production structures, or “PODs” for its cannabis nursery business. Coachella is also home to the company’s statewide distribution headquarters. Both entities operate under LiveWire’s majority owned subsidiary, GHC Ventures. The company is currently in the process to strategically centralize all operations at its recently acquired Paso Robles facility, Estrella Ranch.

Estrella Ranch in Paso Robles, California

Through its subsidiary, Estrella Ranch Partners LLC, LiveWire acquired a 265-acre historic ranch property in Paso Robles, Calif. Estrella Ranch has a longstanding history, once owned by George R. Hearst, the eldest grandson of the late William Randolph Hearst, developer of Hearst Communications, and is considered among the finest ranches in California and the gem of the California Central Coast. LiveWire is transforming this property into the world’s first “Estate-Grown Weedery” with plans to develop it into a vertically integrated, high-end cannabis facility and wellness retreat in California. The stunning property, located in the heart of the world renown California wine country, currently houses three spacious residences, storage areas, and elaborate equestrian facilities with four barns and numerous stables. LiveWire is designing a truly unique property that features indoor and outdoor cannabis operations, including large outdoor and indoor cannabis production. Long-range plans include adding teaching and luxury recreational facilities focused on providing a comprehensive and unique cannabis-related retreat experience.

 

The Paso Robles Nursery

LiveWire has begun the build-out and will soon begin production in its 22,000-square-foot secure indoor cannabis nursery facility in Paso Robles, Calif. The project includes the conversion of two existing buildings with sufficient power capacity and abundant water supply. Floor plans include more than 10,000 square feet of canopy devoted to “mother” plants and separate clone storage; additional space has been identified for flowering plants. Within the two buildings, the nursery also contains research and development areas, rooms for cannabis waste and storage, record keeping and staging space, security offices, a conference room and additional designated locations required for permit approval and compliance.

LiveWire has spent significant resources to research and maneuver a complex legal environment and confirm the economic and environmental feasibility of potential LiveWire cannabis operations in different locations throughout the state of California. All LiveWire operations comply with California state law and local ordinances. To fully capitalize on these highly valuable assets, LiveWire is seeking funding to accelerate the development of its business plan.

GHC Ventures Subsidiary

GHC Ventures, LiveWire’s Coachella-based distribution division, employs a consumer-driven market approach that provides retailers access to a wide range of new high-end cannabis products, all serviced through the licensed and reliable GHC supply chain and distribution network.

GHC Ventures’ distribution network is available exclusively to licensed manufacturers that pass LiveWire’s stringent legal and environmental qualification process. This enables LiveWire to provide a large and solidly structured legal distribution network for all qualifying third-party operators in California. LiveWire is actively seeking to work with licensed operators who are enthusiastic and qualified to ensure the delivery of high-caliber and legal cannabis products for the fast-growing California medical and recreational cannabis markets.

Research Partnerships

LiveWire has established two independent research teams with world-renowned experts in their respective fields to pursue application of cannabis derivatives to specific targeted medical ailments. The company is also establishing research partnerships to explore the application of cannabinoid-based products to target specific ailments or conditions with large “sufferer” populations for both human and veterinarian applications. Possible applications may include dosing verification of zero-pesticide products for quality brands via its 7X Pure Cannabis Dosing and Verification System.

LiveWire has also engaged a highly qualified research team and advisory board to explore the opportunities in the unexplored yet highly valued equine space. The company has entered into consulting and/or advisory board agreements with high-caliber individuals from the medical and international-performance equine sector and is currently exploring strategic relationships with the veterinary departments of leading local and domestic universities and medical facilities.

7X Pure™ Dosing and Verification System

LiveWire Ergogenics is developing its “7X Pure Compliance and Dosage Verification System” intended to provide third-party verification of cannabis material origin, potency, purity, dosage and labeling, securing each product with a digital identity and clearly identifiable chain of custody.

The 7X Pure system will be completely secure, transparent and verifiable, protecting the confidentiality of growers’ and manufacturers’ intellectual property while providing retailers, consumers, government officials and others verification that the growers’ and manufacturers’ claims are true.

The system is designed as a parallel service to the seed-to-sale data provided by marijuana tracking software, will help growers and manufacturers meet increasing compliance requirements related to logistics, quality and transparency. It will also provide a high level of assurance to everyone from end users to municipalities.

Acquisitions & Operations

To maximize the utilization of its fully compliant locations and the licenses granted throughout California, LiveWire has begun and continues to pursue acquisitions of and/or strategic alliances with qualified cannabis companies and consultants. LiveWire will apply a strict regimen to the acquisition of operators, carefully utilizing its experience and legal standing in the California cannabis market for the selection of qualified operators.

Market Opportunity

Legal marijuana is the fastest-growing industry in the United States. Twenty-nine states have already legalized medical marijuana, eight states have approved it for recreational use, and more are following suit. Once the trend toward legalization expands to all 50 states, marijuana could become larger than the organic food industry, according to a new report obtained by The Huffington Post.

The U.S. marijuana industry is forecast to generate annual revenues ranging from $17 billion to $35 billion by 2021. The combined legal medical and recreational market has grown by roughly 30 percent, reaching $6 billion during 2017, according to The Marijuana Business Factbook. The same study projects the market will increase 300 percent to top $17 billion by 2021. During 2017 recreational sales grew by 80 percent, reaching $1.8 billion, not yet accounting for sales of the biggest revenue producer, California, which will only commence with recreational sales in 2018.

Business Model

LiveWire’s diligent approach to the cannabis sector is based on extensive environmental and legal research to predetermine the feasibility of the locations it selects for operations. The company pursues a carefully selected approach of acquiring, licensing and managing self-contained and permitted real estate properties for the development and distribution of its products and leasing to third party operators. LiveWire avoids the complications and high start-up cost of the typical large “growing” operations, instead focusing on becoming the market leader in research, cloning and verification, producing and distributing high quality brands.

Management Team

LiveWire’s team of experienced corporate managers and innovators are leading the company’s plans to capture increasing market share from different and often underserved market sectors in the cannabis industry. LiveWire intends to utilize its team’s experience to accelerate the development and/or acquisition of new properties, product offerings, and companies.

Bill Hodson, CEO & Chairman of the Board
Bill Hodson is responsible for the strategic direction of the firm’s development, branding, sales and marketing strategies. In addition to being responsible for the operation of the company, he leads the development and manages implementation of the company’s innovative product strategy. Previously the executive vice president of LiveWire Sports Group, Hodson was responsible for overseeing all LiveWire’s operations, including the launch of several sports publications and one of the country’s largest sports consumer expos.

As early as five years ago, Hodson recognized the potential of CBD and became an early adopter of CBD as a health and wellness supplement by including hemp-derived cannabidiol in a starburst size edible product. His experience includes not only product development, marketing and sales, but most significantly constant city and county advocacy, guiding the company through four license processes, identifying and spearheading real estate acquisitions, and to assemble operations teams comprised of nursery horticulturists, cultivators and distribution personnel. His vision for the industry is complimented with his out-of-the-box thinking and anticipation of positioning for the future.

Kyle McKay, Horticulturist
Kyle McKay is responsible for managing LiveWire’s controlled cultivation environment, developing new-age genetics to produce consistent and high-quality products for medical patients, and applying his expertise in integrated pest management with Omri-certified fungicides and pesticides. McKay oversees the company’s clone development and supervises both cultivation facilities in Coachella and Paso Robles. He also assists with location research and selection; cultivation center planning; operations set-up; and maximizing the growth potential of cannabis edibles, concentrates and oil production. McKay’s expertise in plant genetics and modern horticulture technology makes him extremely qualified to guide LiveWire’s efforts. During his 12-plus years in the cannabis horticulture field, he has grown more than 230 stable genetics, managed over 27 cultivation centers and grown the specific strains required to meet the needs of up to 45,000 medical cannabis patients at one time.

Advisory Board

Jeff Halloran, Investment Banker
Jeff Halloran is an accomplished senior-management executive with more than 35 years of experience. He has founded and held top positions in large financial and technology firms and has an outstanding record of achievement managing multimillion and billion-dollar programs. Halloran will use his standing in the Canadian markets to provide LiveWire with research and advice for potential acquisitions and strategic alliance targets in the burgeoning Canadian cannabis markets. Halloran has spent most of his career in leading management and consulting positions gathering extensive knowledge in strategic business analysis and information management theories. He served as managing director of Avalon Capital and Halloran Investment, as well as chairman and/or CEO of several companies owned by MT Dynamics. As a consulting manager he was recruited by Oracle Corporation to establish the multibillion-dollar organization’s consulting practice in Canada, eventually earning a place on the design team for Oracle Financials and its CASE Tool and Methodology. Halloran also heads up the executive committee for the Willow Breast Cancer Support Organization.

Michael Corrigan, Attorney at Law
Michael Corrigan is a legal professional at the Law Offices of Michael L. Corrigan, practicing in San Diego, Calif. His practice emphasizes general and SEC representation of emerging high-technology and other operating companies. He has been counsel to private and public companies in a broad range of industries, including computer hardware and software, telecommunications, multimedia and cannabis.

Matthew Geriak, Clinical Pharmacist and Investigational Research Pharmacist
Matthew Geriak is a specialized pharmacist and has a system-wide position on the Investigational Review Board for Sharp Healthcare, which owns five hospitals and various clinics throughout San Diego County. Sharp conducts drug research spanning from phase 1 to 4 human research clinical trials focusing on the fields of oncology, renal and heart transplantations, septic shock treatment, infectious diseases and anticoagulation. Geriak is the primary investigator for retrospective cohorts in the field of infectious diseases.

Jimmy Connors, Sports Industry Adviser
Jimmy Connors is a legendary No. 1 ranked tennis player and is considered among the greatest in the history of the sport. Today, Connors still holds three prominent Open Era Men’s singles records: 109 titles, 1,535 matches played, and 1,256 matches won. His titles include eight?majors, five U.S. Opens, two Wimbledons, one Australian Open, three year-end championships and 17?Grand Prix Super Series. Connors brings a wealth of knowledge in the sports and wellness industries that will be especially important as LiveWire expands into its next phase of development with its topical products. His decade-long exposure in the global sports world as one of the most recognized personalities adds a high level of exposure and supports LiveWire’s efforts to set itself apart in a fast-growing and still turbulent and disruptive industry.

LiveWire Ergogenics Inc. (OTC: LVVV), closed Tuesday's trading session at $0.0059, up 3.5996%, on 1,547,527 volume with 50 trades. The average volume for the last 3 months is 1,177,875 and the stock's 52-week low/high is $0.0035/$0.037399999.

Recent News

chart

InsuraGuest Inc.

The QualityStocks Daily Newsletter would like to spotlight InsuraGuest Inc..

InsuraGuest Inc. was featured today in a publication from NetworkNewsWire, examining how family vacations, solo adventures and business travel are a trillion-dollar business with one thing in common – the potential for accident or loss can occur, even though few people consider the possibility and may not have adequate, or any, traveler’s insurance. Service-as-a-software (SaaS) company InsuraGuest Inc.’s proprietary flagship InsurTech software platform delivers a specialized insurance policy that acts as the first line of defense for clients, properties and guests in an industry that impacts millions of people daily around the globe.

InsuraGuest Inc. is a SaaS (Software-as-a-Service) company utilizing its proprietary flagship InsurTech software platform to provide specialized insurance products to end users in the business-to-business (B2B) and business-to-consumer (B2C) markets. The company’s first focus is on the B2B hotels and vacation rentals sectors, where its API integrates with the clients’ property management systems to offer guests a specialized guest protection policy. The platform and policy combination “InsurTech” product helps transfer the exposure to liability away from the client/property while guests benefit from potential accident and loss coverage during their stay.

InsuraGuest’s platform is currently capable of integrating with approximately 70 different hotel and vacation rental property management systems, giving it access to roughly 40,000 properties worldwide.

The company continues to pursue expansion opportunities and recently signed a Letter of Intent with a master general agent in the United Kingdom and Europe to distribute its platform and products to hotel and vacation rental markets in those regions, as well as plans to expand to Asia in 2020.

Protecting Guests, Enhancing Customer Experience

InsuraGuest is the first line of defense for both the property and the guest.

InsuraGuest is purchased by the hotel or vacation rental “property,” which offers the policy to each registered guest and its occupants for an additional fee. The specialized policy affords coverage for theft of personal property while in the hotel, as well as accidental medical expense and accidental death and dismemberment, up to the policy limits of $2,500 to $50,000.

Market Opportunity

The U.S. hotel industry generated more than $218 billion in annual revenues in 2018, an increase of $10 billion from the previous year, according to STR’s 2019 HOST Almanac. The European market is more than double the size of the U.S. market. According to Oxford Economics, there were 6.4 billion nights stayed in the world, with 2.6 billion hotel nights in Asia, 2.8 billion nights stayed in Europe, and 1.1 billion nights in the United States. Additionally, $100 billion was spent on vacation rentals in the United State alone, where there are approximately 4.5 million second homes are being managed by a third-party rental company.

With distribution in Europe and the United States, InsuraGuest’s demographics combined will total 3.9 billion nights stayed, and will more than double its vacation rental opportunities.

Within this burgeoning, high-demand industry is risk of liability to guest injury. For example, gym injuries are among the top five most common hotel accidents. Without proper hedges in place, the property may be liable in a personal injury claim or lawsuit.

Though the potential for accidents, slip and falls and mishaps can be widespread, it can be covered under the InsuraGuest Specialized Guest Protection Policy to provide guests a worry-free and enjoyable stay that potentially increases loyalty for the property.

Business Highlights

  • Targeting hotels and vacation rentals, a multi-billion-dollar industry
  • Providing the first line of defense in case of accident, loss or death
  • Expanding distribution reach with footing in European hotel and vacation rental markets
  • Expansion into Asia by 2020

Executive Team

Douglas Anderson, Chairman & Chief Executive Officer
Douglas Anderson has been a businessman in the real estate industry for nearly 30 years. His business expertise includes master planning and development implementation for larger-scale resorts, business parks and commercial developments across the USA and two provinces in Canada. His business endeavors include the founding of the 7th larger private equity fund in America focusing on multifamily and senior care (ROC Fund/Bridge IPG Fund). He serves as chairman/founder of a golf and winter sports ski holding company with operations in four major east coast markets and British Columbia, Canada.

Anderson earned a BS undergraduate degree in Consumer Studies with an emphasis in Architecture as an undergraduate at the University of Utah. He subsequently earned his Master’s in Business Administration. He also attended a three-year OPM Program a postgraduate business education at Harvard Business School in Boston. Anderson is an avid skier and outdoor enthusiast.

Charles James Cayias, President & Director
Charles James Cayias is also the president and owner of Charles James Cayias Insurance Inc. He is a third-generation insurance professional whose creativity and artistic vision have enabled him to establish a full-service agency combined with the personal service each client deserves. His outstanding people skills, honesty, integrity and fairness are evident by his loyal and growing clientele, the majority of which are referrals who become long-time customers and friends.

Cayias began his insurance career in the early 1970s and has been licensed since 1977. He is licensed in all 50 states and specializes in niche programs. He has extensive expertise in all aspects of the insurance industry including commercial insurance, employee benefits, workers’ compensation, professional liability, risk management and bonding.

Christopher J. Panos Vice President & Director
Christopher J. Panos is a highly competitive sales professional with over 15 years of territory manager sales experience and an award-winning record of achievements. He is exceptionally well organized with a proven work history that demonstrates self-discipline, superb communication skills, and the initiative to achieve both personal and corporate goals. Panos is successful in building relationships with a large network of industry professionals in order to grow and maintain new and existing business, exceed new sales objectives and provide in-depth product training to authorized dealers and sales personnel.

Alexander Walker III ESQ, Corporate Counsel & Director
Alexander Walker III ESQ has served as director of the company since September of 2018. He also has served as counsel to the company since July of 2018. Walker is an attorney and has been a member of the Utah Bar Association since 1987 and a member of the Nevada State Bar since 2003. His practice has involved general business litigation, in both federal and state courts, and transactional work, including securities offerings and registration, corporate formation and periodic reporting compliance. Walker has provided legal services to emerging businesses throughout his carrier and at times has served as an officer and board member as well as legal counsel public companies. His duties as legal counsel for a public company engaged in the business of ownership and operation of coal-producing properties in the western United States included oversight of corporate-related legal matters including securities reporting, corporate compliance, federal and state mining regulation, and employment law oversight. He also has served as the chair of the Mining Committee of the Energy, Natural Resources and Environmental Law Section of the Utah State Bar, a member of the board of directors of the South East Utah Energy Producers Association, the co-chair of the board of the Western Energy Training Center, a board member of the Utah Supreme Court Committee to Review the ABA Recommendations Regarding the Office of Professional Conduct, and a board member of the University of Utah Crimson Club.

Roger Bloss, Corporate Consultant & Board Advisor
Roger Bloss joined InsuraGuest in August of 2019 to advise the company and its board on hotel transactions, contributing his knowledge from more than 40 years in the hospitality industry. Bloss previously served in executive positions with several major hotel franchise companies and in 1996 founded Vantage Hospitality Group hotel brands. Under his leadership, Vantage became a Top 10 global hotel company and made the Inc. 500/5000 list of Americas’ fastest-growing private companies for eight straight years. Bloss was named Lodging Magazine’s “Innovator of the Year” in 2006 and 2010, and in 2009 earned a spot on HSMAI’s “Top 25 Extraordinary Minds in Sales and Marketing.” Bloss joined Red Lion Hotels Corporation (RLHC) in September 2016 in conjunction with the acquisition of Vantage.


Recent News

chart

No Borders Inc. (OTC: NBDR)

The QualityStocks Daily Newsletter would like to spotlight No Borders Inc. (NBDR).

No Borders Inc. (OTC: NBDR) was featured today in a publication from CBDWire, examining how the cannabidiol (CBD) industry has seen massive growth in the past few years. Valued at $1.8 billion in 2018, the US CBD market is expected to hit $16.32 billion by 2026, a compound annual growth rate of 27.7%. The genesis can be traced back to the 2018 Hemp Farming Act, legislation that legalized the cultivation of industrial hemp, the plant from which cannabidiol, touted as a miracle drug, is extracted.

No Borders Inc. (OTCQB: NBDR) specializes in the acquisition, creation and scaling of commercial products by utilizing cutting-edge technologies designed to reduce costs while increasing revenues and shareholder value. With active subsidiaries in healthcare, education, cannabidiol (CBD), finance and technology, No Borders is uniquely positioned to use its expertise to improve margins and add business lines within target verticals. No Borders is headquartered in Arizona with remote work resources in the U.S., South America, Asia and Europe.

Different by Design

Deeply experienced at actionable data compilation, analysis and utilization, No Borders believes that data utilization in a Web 3 ecosystem of predictive analytics, blockchains, consensus algorithms, IoT and 5G are vital keys to the future of disrupting global business.

The company leverages its technological talent and visionary approach alongside best-in-class branding, messaging and product teams to simultaneously deploy multiple vertical product offerings at the same time.

With resources around the world, No Borders operates as a 100% remote work, lean operating organization with a founding ideological focus on “Lifestyle by Design.” No Borders’ teams are built by allowing people to work when they want and from where they want as long as deliverables and results are achieved. This structure allows for strategic talent acquisition without the need for relocation or commuting; lowered operating and fixed costs; as well as improved morale and substantially increased staff productivity.

NBDR Companies

  • No Borders Dental Resources Inc. provides equipment and supplies to medical and dental professionals across the U.S. through the trade name, MediDent Supplies. MediDent has a strategic focus on expanding product portfolios and optimizing lifetime customer value while minimizing customer acquisition cost in the medical, dental and veterinary spaces.
  • No Borders Naturals is a purveyor of health and wellness products for active consumers and their pets. No Borders Naturals aims to be an industry leader in alternative wellness product offerings and is currently expanding its digital offering with impactful product up-sell opportunities such as a series of “Buy Two-Get One” on products on its 1000mg CBD tincture, collagen and retinol beauty cream.
  • No Borders Labs Inc. provides leading-edge tech tools to the No Borders family of companies along with building, testing and deploying technology solutions and products to the market while also offering consulting, architecture and software development services to external businesses looking to update their technology infrastructure for greater efficiency, security and transparency.
  • No Borders Funding Inc. provides internal capital and strategic funding options for the family of No Borders companies while actively engaging and networking to find, acquire, structure and deploy unique financial products, solutions and systems with traditional, distributed ledger and blockchain technologies.
  • No Borders Education Inc. provides internal staff training and strategic education tools for the No Borders family of companies while pursuing external revenue generating educational opportunities within the verticals for which No Borders deploys products, services or technologies.

 

Leadership

No Borders CEO Joseph Snyder is a serial entrepreneur whose experiences in real estate investment, financial services and digital strategy over the last 15 years provide a strong, grounded foundation for the structure and ideas outlined in the company’s strategic plan. He brings a unique set of long-term business experiences that provide No Borders with a clear “mile-high” view of the intricately linked systems and challenges associated with growing and scaling our vision.

COO Cynthia Tanabe, a licensed real estate agent/broker since 2004, has successfully built a highly respected investor and bank-focused real estate and property management firm in Arizona with tens of millions of dollars of properties owned and sold.

CTO Chris Brown has 14 years of experience in the IT industry ranging from full stack programming, hardware support, engineering and maintenance, to enterprise-level information system analysis, design, development and implementation. From his background in Air Force intelligence to earning dual B.S. degrees in computational mathematics and biochemistry from Arizona State University, Brown has been engrossed with technologies such as artificial intelligence, machine learning, and decentralized blockchain ledger systems and their connections with real world business applications.

Management is backed by an advisory board with a diverse range of expertise blockchain, brand development, specialty retail, branded consumer products, technology, marketing and other specialties pertinent to No Borders’ growth strategy.

No Borders Inc. (NBDR), closed Tuesday's trading session at $0.017, even for the day, on 48,590 volume with 3 trades. The average volume for the last 3 months is 68,587 and the stock's 52-week low/high is $0.007699999/$0.048799999.

Recent News

chart

Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

Youngevity International, Inc. (NASDAQ: YGYI) was featured today in the 420 with CNW by CannabisNewsWire. The Drug Enforcement Administration’s (DEA) plans for authorizing the cultivation of 3.2 million grams of marijuana for research purposes in the 2020 planting season has been finalized. The 3.2 million grams is a 30% increase from 2019.

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed Tuesday's trading session at $4.00, off by 3.6145%, on 72,259 volume with 2,617 trades. The average volume for the last 3 months is 44,290 and the stock's 52-week low/high is $3.70000004/$9.27999973.

Recent News

chart

Green Hygienics Holdings Inc. (OTC: GRYN)

The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (GRYN).

Green Hygienics Holdings (OTCQB: GRYN), an innovative premium cannabis cultivation and branding enterprise, today announced the appointment of Sid Senroy, MBA, as its Head of Quality and Compliance. In this advisory role, Senroy will facilitate GRYN in establishing cross-functional alliances for improvement and growth, and will work to increase levels of productivity, compliance and efficiencies. To view the full press release, visit http://cnw.fm/oImX3.

Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium hemp cultivation and branding enterprise focused on the cultivation and processing of industrial hemp for the purpose of extracting cannabidiol (CBD). With more than 25 years of experience in agricultural science and innovation, Green Hygienics aims to become one of the largest providers of industrial hemp-derived CBD products on the planet.

Green Hygienics’ business model includes generating revenues from the sale of hemp and premium-grade CBD products, creating trusted global consumer brands, developing valuable intellectual property (IP) and growing rapidly through strategic acquisitions. With direct regard to acquisitions, the company acts as a business accelerator and a vertical integrator supporting rapid growth and development of companies with extraordinary potential.

Innovation – the Future of Commercial Cultivation

The greatest challenge of the cannabis industry is determining how to deliver a safe and premium-quality product on a consistent basis; antiquated production methods are riddled with recalls and are unsafe from a cultivation production standpoint. Green Hygienics’ solution is to employ scientific methodology combined with sustainable farm practices to achieve optimal soil refinement. The company’s objectives are to produce higher yields and a superior product on a consistent basis to always remain compliant through diligent testing. A secure, premium-quality supply chain is the foundation for the company’s operations.

Green Hygienics’ cultivation approach is based on scientific measurements and data analysis, which transform the cultivation environment into a laboratory environment to deliver superior product.

State-of-the-Art Processing

Processing hemp to produce the finest-quality CBD is a complex, multistage process that should be performed with adherence to the highest standards. Once harvested, the hemp must be carefully handled, dried and stored to prepare it for CBD extraction. Each and every step must be given full care and attention. Green Hygienics’ ambition is to create state-of-the-art infrastructure, employ the latest large-scale processing technologies and adhere to strict quality management systems.

The company strives to constantly develop innovations in industrial hemp for CBD cultivation and to create solutions that lower costs, deliver higher yields and address the challenges of large-scale production.

Brand Development, Marketing and Direct Sales

One of the core drivers of the Green Hygienics business model is to develop or acquire unique brands with global distribution potential. The company sees the market becoming increasingly competitive, and establishing Green Hygienics’ own distinct, trusted brands will be important. By controlling its own supply chain, the company can also leverage strategic advantages in the marketplace, such as the ability to deliver a “best in class” product on a consistent basis. Successful branding is demonstrated by a positive response to a company’s customer service, reputation and products, and Green Hygienics Holdings is acutely aware of the value in this.

Ahead of the Curve

The clear competitive advantage Green Hygienics holds over industry peers is cultivating premium product within the upper-scale product category more efficiently than anyone else in the industry. Currently, the average-size hemp farm in North America is 9 acres. Green Hygienics addresses the challenge of scalability through its farming methodology.

The company’s objective is to produce a higher quality of product at a lower cost and to deliver the finest-quality product to consumers without exception.

In today’s market, inefficient companies and those that produce an inferior product will become vulnerable or disappear, adding considerable value to companies like Green Hygienics that efficiently innovate and operate. The premium cannabis market will continue to achieve higher pricing, and the demand will stabilize. At the end of the day, successful branding backed by superior product will cause companies like Green Hygienics to rise above the competition.

Outlook

Companies within the cannabis sector, states and lawmakers are still figuring out how legislation, consumer demand and innovations will shape the industry. As a safeguard and for long-term resilience, Green Hygienics is preparing for the next plateau with proprietary cultivation and processing systems and tightly controlled growth environments that enable containment of production costs, delivery of higher yields and production of a premium product. These margins will provide the company with a strategic advantage within an increasingly competitive marketplace.

Green Hygienics is constantly studying the market dynamics in North America and abroad and anticipates that both the domestic and international markets will appreciate and be willing to pay a premium to those companies that can deliver best-in-class products.

In line with this expectation, the company’s additional objectives are to secure investment, enhance its balance sheet and increase its value through profitable operations as well as through acquiring and owning the real estate or land it builds upon. Over the long term, this will help Green Hygienics grow in value, provide leverage for rapid expansion and offer security for investors. The company will be positioned to capitalize on any opportunity within the industry or to acquire distressed assets, which is part of its growth strategy.

Green Hygienics plans to establish lead brands starting in the California market, to secure trademarks, and to develop and secure intellectual property assets with regard to cultivation and processing.

Green Hygienics Holdings Inc. (GRYN), closed Tuesday's trading session at $2.00, off by 7.4074%, on 1,832 volume with 14 trades. The average volume for the last 3 months is 17,117 and the stock's 52-week low/high is $0.100100003/$2.48000001.

Recent News

chart

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV) (CNPOF).

Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) was featured today in a publication from HempWireNews, examining how Wisconsin Governor Tony Evers signed a hemp production legislation that amends laws governing industrial hemp cultivation. He also signed a bill legalizing temporary lemonade stands for children under the age of 18.

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (CNPOF), closed Tuesday's trading session at $1.035, off by 0.48%, on 85,456 volume with 154 trades. The average volume for the last 3 months is 143,426 and the stock's 52-week low/high is $0.78/$4.78.

Recent News

chart

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

SRAX Inc. (NASDAQ: SRAX) sits at the epicenter of consumer privacy and data ownership. Leveraging its BIGtoken platform, the Company has made it possible for consumers to own their own data and get paid for the release of that data while also creating specific data sets around highly valuable verticals. On November 13, 2019, SRAX hosted a conference call for executives to share Q3 earnings and a forward look into Q4 with investors (http://nnw.fm/72m3W).

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Tuesday's trading session at $1.256, off by 1.1024%, on 121,787 volume with 314 trades. The average volume for the last 3 months is 100,803 and the stock's 52-week low/high is $1.12999999/$5.8499999.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) was featured today in a publication from CBDWire, examining how the cannabidiol (CBD) industry has seen massive growth in the past few years. Valued at $1.8 billion in 2018, the US CBD market is expected to hit $16.32 billion by 2026, a compound annual growth rate of 27.7%. The genesis can be traced back to the 2018 Hemp Farming Act, legislation that legalized the cultivation of industrial hemp, the plant from which cannabidiol, touted as a miracle drug, is extracted.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed Tuesday's trading session at $0.88, off by 6.6313%, on 186,026 volume with 216 trades. The average volume for the last 3 months is 244,905 and the stock's 52-week low/high is $0.739199995/$5.20499992.

Recent News

chart

Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF)

The QualityStocks Daily Newsletter would like to spotlight Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF).

Willow Biosciences Inc.  (CSE: WLLW; OTCQB: CANSF), commented today on Purisys, LLC's ("Purisys") news release issued on November 21st stating that the U.S. Drug Enforcement Agency (the "DEA") has removed Purisys' CBD from Schedule I of the Controlled Substances Act (the "CSA").  Purisys is the spin-out entity of Noramco, Inc.'s ("Noramco") industry-leading cannabinoids business, which began to operate as a stand-alone entity from Noramco on October 1st, 2019 and is expected to become independent from Noramco on January 1st, 2020. Also today, the company announced that it has received final approval from the Toronto Stock Exchange (the "TSX") to list its common shares (the "Common Shares") on the TSX. The Common Shares will commence trading on the TSX effective as of the open of the market on Thursday, December 5, 2019. Upon listing on the TSX, the Common Shares will continue to trade under the symbol "WLLW". In conjunction with listing on the TSX, the Common Shares will concurrently be delisted from the Canadian Securities Exchange. On January 15, 2020, Willow will also participate in the market open ceremony. Additionally, the company was featured in the 420 with CNW by CannabisNewsWire.

Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) is a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates. The company’s cannabidiol (“CBD”) yeast-based biosynthesis program produces a high yield, ultrapure, low-cost and scalable manufacturing solution for pharmaceutical, food, beverage and personal care consumers of CBD.

The company is headquartered in Calgary, Alberta, Canada.

Biosynthesis Platform

Willow’s proprietary yeast-based lab strains produce CBD, tetrahydrocannabinol (“THC”), and cannabigerol (“CBG”), as well as certain minor and novel cannabinoids.

The company’s expertise in the esoteric field of biosynthesis and in delivering commercial fermentation pathways for the production of pharmaceutical-grade compounds grew from its origins in opiate research. Willow recently delivered a de novo biosynthesis pathway in yeast for thebaine, a key precursor API used as a feedstock in the manufacture of semi-synthetic opiates such as naloxone (used to reverse opioid overdose) and several common analgesics. Led by Chief Scientific Officer Dr. Peter Facchini, Willow’s research team discovered and patented numerous previously unknown genes coding for core catalytic pathway enzymes, as well as a number of additional non-pathway, yet commercially-essential, accessory genes.

Utilizing this proven synthetic biology platform, Willow’s research team has already begun producing cannabinoids at lab scale, using yeast as the host cell “factory.” This biosynthetic fermentation-based process is capable of producing pharmaceutical grade CBD in 10 days – far less time than traditional plant-based extraction methods.

Willow anticipates its technology can be scaled to produce hundreds of kilograms per batch of cannabinoid API at less than $1,000 per kilogram, thus costing approximately 60% less than current chemical synthesis methods and 90% less than conventional plant-based extraction methods.

World-Class Collaboration

Willow and Noramco Inc., the world’s largest producer of high-quality synthetic cannabinoid APIs and other controlled substance APIs for the pharmaceutical and healthcare industry, have an exclusive, worldwide Joint Development Agreement (“JDA”) to design a yeast-based biosynthesis platform for the production and distribution of a highly pure CBD isolate.

The mutually exclusive agreement calls for Willow to be responsible for optimizing yeast strains in a biosynthetic process to generate ultrapure CBD at high yield and substantially lower cost compared to current methods. Noramco will leverage its decades of experience in producing and delivering CBD and pharmaceutical APIs by being responsible for the scale-up, regulatory submission, marketing and distribution of products manufactured under the JDA.

Each company will invest comparable funds, will retain the intellectual property associated with their respective scopes of work and share equally in gross profits from sales of products manufactured under the JDA.

Market Opportunity

The agreement with Noramco (http://nnw.fm/Mz1vW) addresses the increasing demand for CBD-based APIs and other CBD-infused products by pharmaceutical, nutraceutical, consumer packaged goods, beverages and other industry sectors.

The U.S. market potential of cannabinoids is significant, with industry analysts projecting $50 billion in cannabinoid-based pharmaceutical sales and $16 billion in CBD consumer goods retail sales by 2025. As of June 2019, 34 U.S. states and the District of Columbia, Guam, Puerto Rico and U.S. Virgin Islands have legalized cannabis for medical use. Another 13 states and territories have approved recreational cannabis for adult use while other states are considering similar measures.

The cannabinoid API market continues to evolve with CBD and other cannabinoid-based treatment options currently in clinical trials for indications such as post-traumatic stress syndrome, epilepsy, Parkinson’s disease, chronic pain, schizophrenia, cancer treatments and other challenging unmet medical conditions.

Capitalization

Willow is fully funded after raising $29 million via private placement and $8 million in exercised warrants by Tuatara Capital Fund II, L.P. Proceeds of the funding will be used to enhance the existing laboratory space in Calgary and Vancouver, Canada, and in San Francisco, California. The company anticipates exiting 2020 with $15.8 million in cash.

Leadership

President and CEO Trevor Peters is an experienced executive who co-founded four startup companies in the past 15 years. He has raised over $1 billion in equity and debt financings at various stages of corporate development and has been integral to successful transactions totaling over $4 billion on sale. Mr. Peters previously was chief financial officer at Caracal Energy Inc., which sold to Glencore plc in 2014 for $1.8 billion.

Chief Financial Officer Travis Doupe has over 18 years of experience in financial leadership roles, principally in the international oil and gas industry, where he provided corporate strategic direction while overseeing all aspects of financial operations. Mr. Doupe is the treasurer and a member of the board of directors of the Canada Council for the Americas – Alberta and holds a CA-CPA designation and earned a bachelor’s degree in management from the University of Calgary.

Dr. Peter Facchini, Chief Scientific Officer, has been professor of plant biochemistry in the Department of Biological Sciences at the University of Calgary since 1995. He is recognized internationally as a leader in plant specialized metabolite biosynthesis. Dr. Facchini is the Canada Research Chair in Plant Metabolic Processes Biotechnology and has published more than 150 research papers and scholarly articles. Dr. Facchini received a PhD from the University of Toronto and conducted postdoctoral research at the University of Kentucky and Université de Montréal.

Dr. Joseph Tucker, Executive Chairman of the Board of Directors, holds more than 20 issued or pending patents and is a member of the Board of Directors of BioAlberta. He has extensive senior leadership experience in multiple public and private biotech companies. Dr. Tucker received a PhD in biochemistry and molecular biology from the University of Calgary.

Willow Biosciences Inc. (OTCQB: CANSF), closed Tuesday's trading session at $0.44, off by 5.3763%, on 50,700 volume with 7 trades. The average volume for the last 3 months is 6,815 and the stock's 52-week low/high is $0.423999994/$2.1775.

Recent News

chart

Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)

The QualityStocks Daily Newsletter would like to spotlight Sproutly Canada, Inc. (SRUTF).

Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) (“Sproutly" or the “Company”) is pleased to announce that the Company’s wholly-owned subsidiary Toronto Herbal Remedies (“THR”) has entered into a cannabis standing offer contract with the province of Alberta (the “Supply Agreement” or the “Agreement”) from Alberta Gaming, Liquor & Cannabis (“AGLC”), the province’s wholesaler and operator of Alberta’s only legal online recreational cannabis store, AlbertaCannabis.org. Pursuant to the Supply Agreement, Sproutly will supply AGLC with its indoor-grown dried flower products produced from THR, under the Company’s premium cannabis brand ‘CALIBER’. The Alberta Supply Agreement is the Company’s first executed provincial supply agreement for cannabis flower to date.

Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.

To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.

This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.

Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.

Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.

Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.

Management

Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.

President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.

Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.

Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.

Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.

Sproutly Canada, Inc. (OTCQB: SRUTF), closed Tuesday's trading session at $0.152, off by 1.9355%, on 411,833 volume with 93 trades. The average volume for the last 3 months is 206,349 and the stock's 52-week low/high is $0.150000005/$0.850000023.

Recent News

chart

Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF)

The QualityStocks Daily Newsletter would like to spotlight Wonderfilm Media Corporation (OTC: WDRFF).

Wonderfilm Media Corporation (TSX.V: WNDR) (OTCQB: WDRFF), a leading entertainment company producing internationally appealing feature films and episodic television, is working on quality theatrical releases and entertainment content for an increasing number of streaming services. Company CEO Kirk Shaw, a veteran producer of 240 movies including the Oscar-winning The Hurt Locker, discussed Wonderfilm Media Corporation’s business model, production plans, talent and expansion in an exclusive interview with NetworkNewsWire (http://nnw.fm/v9ZrO).

Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF) main business is the worldwide production of high-quality feature films and episodic television. The Wonder?lm team includes Hollywood veterans who have packaged, produced and delivered several profitable recent films, including “BlacKkKlansman,” “Get Out” and “The Hurt Locker.” Having these individuals on the Wonderfilm team demonstrates the company’s proven access to Academy Award-quality films and upside.

Wonder?lm maintains a continuing $58 million annual production slate to meet the constant and growing need for content worldwide. The company’s risk-averse production process results in predictable and consistent revenue streams.

Soaring demand for content from streaming providers is fueling industry growth. The global media and entertainment market is expected to grow from $1.9 trillion in 2017 to $2.4 trillion in 2022, a five-year CAGR of 4.4%.

The company recently formed Wonderfilm Global, an international film and television sales and distribution joint venture that is expected to generate significant incremental revenue.

Wonderfilm has strong relationships throughout the entertainment industry, which enables cost-effective production budgets and in-demand content creation.

Management Team with Proven Track Records

Kirk Shaw: Over 240 movies and seven television series to his credit. Headed up Canada’s largest independent film and television production company, attaining $100 million revenue two years straight with 8% EBITDA.

Dan Grodnik: Founded Mass Hysteria Entertainment, a publicly traded company, and became its chairman/CEO. Produced over 50 feature films, including “Bobby,” the 2006 Robert Kennedy biographic film.

Shaun Redick & Yvette Yates: $300 million+ USD total production budgets to date with a combined 175 award wins/355 nominations, including 10 Oscar nominations. In 2017 and 2018, they produced two of the most successful Hollywood films of those years: “Get Out” ($255 million USD gross revenue) and “BlacKkKlansman” ($100 million USD gross revenue). Scheduled to produce two to three films per year for Wonderfilm, with the first release slated for October 2020. Committed to the 4% challenge to give more women and women of color the opportunity to direct.

Jeff Bowler: 2017 Emmy Award-winning producer. Vice president of acquisitions and production for The Exchange, one of the top film sales and finance companies in the world. Bowler is the executive for Wonderfilm Global distribution.

Bret Saxon: Through his company, TMP Inc., Saxon created M&A deals worth over US$750 million across 113 countries. Produced several feature films and made-for-television movies, including Wonderfilm’s 2019 movie “Zombie Tidal Wave” for NBC/Universal’s SYFY.

17-Title Movie Slate — Greenlit

Wonderfilm currently has 17 films greenlit with combined budgets totaling $58 million. Wonderfilm production stars include: John Travolta, Nicolas Cage, Guy Pearce, Ryan Phillippe and Anne Heche, to name a few.

Some of the company’s most notable greenlit projects include the horror film “Amityville 1974,” slated for theatrical release in October 2020, and the action film “Inside Game” starring Tyrese Gibson, which will be released to theaters in fall 2020.

The company is also actively developing a number of other new IP projects, including a dramatic biographic feature titled “Life and Times of Steve McQueen,” a film adaptation of the bestselling novel “Merchant of Death” and a television series headed by “CSI: Crime Scene Investigation” creator Anthony Zuiker.

 

Potential for Breakout Success

Wonderfilm movies have the potential for millions of dollars in revenue from the kind of breakout success generated by films like “Saw” and “Get Out,” which would propel Wonderfilm and its revenue streams to a new level. Wonderfilm has several potential breakout films in its development/production queue.

Note: Potential breakout films are not factored into company’s revenue projections.

Base Hits and Home Runs

In tandem with its slate of high-profile films, Wonder?lm continues to finance, produce and deliver many profitable low-risk, lower-budget films that are base hits. Shaun Redick is a home run hitter, and his upcoming Wonderfilm projects are anticipated to be home run hits for the company, while base hits such as “Zombie Tidal Wave” provide a consistent source of revenue.

Recent Industry Breakout Films Include:

  • SAW – $1.2 million budget = $103.9 million in sales
  • Pulp Fiction – $8 million budget = $212 million in sales
  • My Big Fat Greek Wedding – $5 million budget = $250 million in sales
  • Lost in Translation – $4 million budget = $120 million in sales
  • Get Out – $4.5 million budget = $255.5 million sales (Shaun Redick)

Note: Revenue from most of Wonderfilm’s current slate will be recorded on the books in 2020 or 2021.

Recent Wonderfilm Releases

  • Aug. 17, 2019: Co-produced with NBC/Universal, “Zombie Tidal Wave” premièred on the SYFY channel to strong ratings.
  • Aug. 29, 2019: “The Fanatic” starring John Travolta opens in U.S. theaters.
  • Sept. 5, 2019: “Tammy’s Always Dying” premiers at Toronto Film Festival.
  • Nov. 8, 2019: “Primal” starring Nicolas Cage opens in U.S. theaters.

Wonderfilm Global Distribution

At the 2019 Cannes Film Festival, Wonderfilm officially launched Wonderfilm Global, a new film, television and media foreign sales/distribution joint venture with 101 Films and Paul McGowan.

Wonderfilm acquired 51% ownership in the joint venture structure and immediately began attaching its own productions to Wonderfilm Global. The joint venture represents a significant opportunity for Wonderfilm, changing how the company does business.

The intention behind Wonderfilm Global is to keep distribution margins in-house that previously went to other companies. Since most Wonderfilm movies are relatively low-risk and easy to sell because they feature desirable cast and genre, third-party distribution companies were previously earning approximately 10%, plus expenses, on Wonderfilm movies without any level of risk. Now, revenue is generated through presales of Wonder?lm projects and, at times, third-party films. The average Wonder?lm movie is pre-sold for $5million, garnering $500,000 to $750,000 per sale as a commission. These commissions now stay in-house with Wonder?lm Global, and the company expects to sell 10 to 12 third-party films between fall 2019 and fall 2020, generating roughly $6 million in commission income.

A further revenue source is generated from theatrical sales through a 50/50 upside split once the minimum sales threshold is met.

Wonder?lm Global has offices in Vancouver, Beverly Hills, London, Ireland, Seoul and China.

Wonderfilm Business Model

Wonderfilm productions are structured to begin generating a return to the company as soon as the camera starts rolling.

Return Before a Film is Delivered: Producer fee line items are included in each production budget. These range from $50,000 to $500,000, depending on the total budget, and are paid to Wonderfilm most commonly on the first day of principle photography.

Distribution: Wonderfilm Global charges sales and distribution fees within each production budget to cover its presale costs.

Note: Wonderfilm’s productions are all structured to minimize risk by matching budget to funds available.

Return After a Film is Delivered: Unsold presale territories are countries or territories left off of a film’s presale list, either for strategic reasons or because the broadcaster/distributor is waiting to see the completed film. These outside-the-budget distribution sales become Wonderfilm profit centers.

Sales overages once contracted presale threshold is surpassed.

The company’s film library grows with each new production, adding to future sales revenue. Depending on the agreement, exploitation rights for future worldwide sales return to Wonderfilm four or seven years after delivery. As of October 2019, Wonderfilm’s growing film library comprises 18 titles for future exploitation.

Note: The nature of the film business is that box office revenue lags production up to a couple of years.

$50 Million Wonderfilm Production Fund (WPF):

Wonderfilm is in the process of raising $50 million to establish a Wonderfilm Production Fund (WPF). WPF is designed to consolidate traditional production financing models into a single diversified, asset-backed debt instrument.

The WPF is a highly specialized investment vehicle with noncorrelated market returns normally reserved for institutional banks and specialty lenders, and it would pay 8% interest directly from each Wonderfilm movie or series budget and not from corporate funds. These same interest payments are already added to each production budget, as the company currently closes a separate financing for every film. The WPF would significantly streamline Wonderfilm’s production rate, adding revenue more quickly and broadening the yearly production slate.

For fund investors, the WPF is a dedicated production-financing vehicle designed to offer a risk-moderated approach to investing in film finance. The managed process provides structure and reassurance that are normally experienced only when working with an institutional lender that has a dedicated staff and resources.

All projects being financed are for Wonderfilm productions, with the fund collateral fully secured by receivables, including presale contracts, government incentives, or a guarantee from Wonderfilm for any unsecured amounts as may be permitted.

Wonderfilm Media Corporation (OTC: WDRFF), closed Tuesday's trading session at $0.10, off by 1.4778%, on 15,500 volume with 3 trades. The average volume for the last 3 months is 42,558 and the stock's 52-week low/high is $0.075099997/$0.49081999.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade (OTCQB: SGMD), a major supplier to the hydroponic cultivation and hemp sectors, is pursuing an aggressive merger and acquisition (“M&A”) roll-up strategy to position itself as a leader in the hydroponics sector. The company is presently in preliminary talks with six hydroponic and agricultural supply targets in the U.S. and central Europe. To view the full press release, visit http://cnw.fm/pnl6S

Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base. 6

Sugarmade, Inc. (SGMD), closed Tuesday's trading session at $0.01308, off by 3.1111%, on 2,205,165 volume with 103 trades. The average volume for the last 3 months is 6,489,106 and the stock's 52-week low/high is $0.0073/$0.125.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.